相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Randomized Double-Blind Placebo Controlled Study Assessing the Anti-Inflammatory Effects of Ketamine in Cardiac Surgical Patients (Retraction of vol 20, pg 217, 2006)
Ervant Nishanian et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2014)
Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
Rong-Jian Liu et al.
BIOLOGICAL PSYCHIATRY (2012)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial
Amit Anand et al.
BIPOLAR DISORDERS (2012)
Ketamine as a Novel Antidepressant: From Synapse to Behavior
J. W. Murrough
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Ketamine for Treatment-Resistant Unipolar Depression Current Evidence
Sanjay J. Mathew et al.
CNS DRUGS (2012)
Investigational NMDA receptor modulators for depression
Bernadeta Szewczyk et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorder
Andrew Stuart Gibbons et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf(+/-) heterozygous null mice
Jesse S. O. Lindholm et al.
NEUROPHARMACOLOGY (2012)
Signaling pathways underlying the rapid antidepressant actions of ketamine
Ronald S. Duman et al.
NEUROPHARMACOLOGY (2012)
Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders
Gerard Sanacora et al.
NEUROPHARMACOLOGY (2012)
Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study
Lobna Ibrahim et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
Brian Leonard et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
Overview of glutamatergic neurotransmission in the nervous system
Mark J. Niciu et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Anita E. Autry et al.
PHARMACOLOGICAL REVIEWS (2012)
Trajectories of Depression Severity in Clinical Trials of Duloxetine Insights Into Antidepressant and Placebo Responses
Ralitza Gueorguieva et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Relationship Between Genetic Variation in the Glutaminase Gene GLS1 and Brain Glutamine/Glutamate Ratio Measured In Vivo
Dost Oenguer et al.
BIOLOGICAL PSYCHIATRY (2011)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
Inflammatory and Neurodegenerative Pathways in Depression: A New Avenue for Antidepressant Development?
M. Catena-Dell'Osso et al.
CURRENT MEDICINAL CHEMISTRY (2011)
If at First You Don't Succeed A Review of the Evidence for Antidepressant Augmentation, Combination and Switching Strategies
K. Ryan Connolly et al.
DRUGS (2011)
Use of memantine for the treatment of dementia
Daphne Lo et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2011)
Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data
Konstantinos N. Fountoulakis et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
被撤回的出版物: A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department (Retracted article. See vol. 20, pg. 611, 2017)
Gregory Luke Larkin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Placebo, Prozac and PLoS: significant lessons for psychopharmacology
Jamie Horder et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
E. Beurel et al.
MOLECULAR PSYCHIATRY (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders
Ann Gardner et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
M. Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS
Gerald W. Valentine et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2011)
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor
Valerio Ricci et al.
PSYCHOPHARMACOLOGY (2011)
Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576
Roberta Bursi et al.
PSYCHOPHARMACOLOGY (2011)
Translating Glutamate: From Pathophysiology to Treatment
Daniel C. Javitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Regulation of neural process growth, elaboration and structural plasticity by NF-κB
Humberto Gutierrez et al.
TRENDS IN NEUROSCIENCES (2011)
Ketamine Inhibits Transcription Factors Activator Protein 1 and Nuclear Factor-kappa B, Interleukin-8 Production, as well as CD11b and CD16 Expression: Studies in Human Leukocytes and Leukocytic Cell Lines
Ingeborg D. Welters et al.
ANESTHESIA AND ANALGESIA (2010)
Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling
Bruce S. McEwen
EPIGENETICS AND NEUROPSYCHIATRIC DISEASES: MECHANISMS MEDIATING NATURE AND NURTURE (2010)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Magnetic Resonance Spectroscopy Studies of the Glutamatergic System in Mood Disorders: A Pathway to Diagnosis, Novel Therapeutics, and Personalized Medicine?
Giacomo Salvadore et al.
BIOLOGICAL PSYCHIATRY (2010)
Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders
Cagri Yuksel et al.
BIOLOGICAL PSYCHIATRY (2010)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice
Francisca Charliane Carlos da Silva et al.
BRAIN RESEARCH BULLETIN (2010)
Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
John H. Krystal et al.
CNS DRUGS (2010)
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
Sanjay J. Mathew et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Rapid Resolution of Suicidal Ideation After a Single Infusion of an N-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
Nancy DiazGranados et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
A Hypothesized Role for Dendritic Remodeling in the Etiology of Mood and Anxiety Disorders
J. M. Gorman et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)
A Glutamate Pathway to Faster-Acting Antidepressants?
John F. Cryan et al.
SCIENCE (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
mTOR signaling: At the crossroads of plasticity, memory and disease
Charles A. Hoeffer et al.
TRENDS IN NEUROSCIENCES (2010)
Glutamatergic Modulators: The Future of Treating Mood Disorders?
Carlos Zarate et al.
HARVARD REVIEW OF PSYCHIATRY (2010)
Regulation and Function of NF-kappa B Transcription Factors in the Immune System
Sivakumar Vallabhapurapu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
Rebecca B. Price et al.
BIOLOGICAL PSYCHIATRY (2009)
Family History of Alcohol Dependence and Initial Antidepressant Response to an N-methyl-D-aspartate Antagonist
Laura E. Phelps et al.
BIOLOGICAL PSYCHIATRY (2009)
Effect of low-dose ketamine on inflammatory response in off-pump coronary artery bypass graft surgery
J. E. Cho et al.
BRITISH JOURNAL OF ANAESTHESIA (2009)
Glycogen synthase kinase 3: more than a namesake
Geetha Vani Rayasam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials
John R. Geddes et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
Rodrigo Machado-Vieira et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to an N-Methyl-D-Aspartate Antagonist
Rodrigo Machado-Vieira et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling
J. M. Bessa et al.
MOLECULAR PSYCHIATRY (2009)
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression
Michael Maes et al.
METABOLIC BRAIN DISEASE (2009)
ANXIOLYTIC- AND ANTI DEPRESSANT-LIKE PROPERTIES OF KETAMINE IN BEHAVIORAL AND NEUROPHYSIOLOGICAL ANIMAL MODELS
E. Engin et al.
NEUROSCIENCE (2009)
BRAIN-DERIVED NEUROTROPHIC FACTOR AS A MODEL SYSTEM FOR EXAMINING GENE BY ENVIRONMENT INTERACTIONS ACROSS DEVELOPMENT
B. J. Casey et al.
NEUROSCIENCE (2009)
Stress-induced prefrontal reorganization and executive dysfunction in rodents
Andrew Holmes et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)
The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders
Rodrigo Machado-Vieira et al.
NEUROSCIENTIST (2009)
BDNF Activates mTOR to Regulate GluR1 Expression Required for Memory Formation
Leandro Slipczuk et al.
PLOS ONE (2009)
Effect of co-administration of fluoxetine and amantadine on immunoendocrine parameters in rats subjected to a forced swimming test
Zofia Rogoz et al.
PHARMACOLOGICAL REPORTS (2009)
Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats
Leda S. B. Garcia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Meta-analysis of depression and substance use among individuals with alcohol use disorders
Kenneth R. Conner et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2009)
Adverse events associated with ketamine for procedural sedation in adults
Reuben J. Strayer et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2008)
Chronic Administration of Ketamine Elicits Antidepressant-Like Effects in Rats without Affecting Hippocampal Brain-Derived Neurotrophic Factor Protein Levels
Leda S. Garcia et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Riluzole in psychiatry: a systematic review of the literature
Carlos A. Zarate et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression
S. Chourbaji et al.
FASEB JOURNAL (2008)
Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence
Leea H. Muhonen et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Rapid onset of antidepressant action: A new paradigm in the research and treatment of major depressive disorder
Rodrigo Machado-Vieira et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
Sheldon H. Preskorn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
Leda S. B. Garcia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration
Irving Kirsch et al.
PLOS MEDICINE (2008)
Neuroprotection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy
Georgios Papazisis et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Stress, depression, and neuroplasticity: A convergence of mechanisms
Christopher Pittenger et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression
Mark A. Frye et al.
NEUROPSYCHOPHARMACOLOGY (2007)
The immune-mediated alteration of serotonin and glutamate:: towards an integrated view of depression
N. Mueller et al.
MOLECULAR PSYCHIATRY (2007)
AMPA receptor potentiators: Application for depression and Parkinson's disease
Michael J. O'Neill et al.
CURRENT DRUG TARGETS (2007)
The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: Relationship to clinical effects in mood disorders
Jing Du et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Reduced prefrontal glutamate/glutamine and γ-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy
Gregor Hasler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Low cerebrospinal fluid glutamate and glycine in refractory affective disorder
Mark A. Frye et al.
BIOLOGICAL PSYCHIATRY (2007)
Bipolar depression: a review of randomised clinical trials
Paul J. Goodnick
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Glutamate-mediated neuronal-glial transmission
Alexei Verkhratsky et al.
JOURNAL OF ANATOMY (2007)
N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
Mannie M. Y. Fan et al.
PROGRESS IN NEUROBIOLOGY (2007)
The glutamate story
JC Watkins et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Behavioral effects of aminoadamantane class NMDA receptor antagonists on schedule-induced alcohol and self-administration of water in mice
Tobie Escher et al.
PSYCHOPHARMACOLOGY (2006)
Correlation between plasma levels of glutamate, alanine and serine with severity of depression
Hideaki Mitani et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: A systematic review of the in vivo proton magnetic resonance spectroscopy findings
Aysegul Yildiz-Yesiloglu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
NR2B-containing N-methyl-D-aspartate subtype glutamate receptors regulate the acute stress effect on hippocampal long-term potentiation/long-term depression in vivo
Meina Wang et al.
NEUROREPORT (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A neurotrophic model for stress-related mood disorders
Ronald S. Duman et al.
BIOLOGICAL PSYCHIATRY (2006)
Effect of amantadine and imipramine on immunological parameters of rats subjected to a forced swimming test
Marta Kubera et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice
T Kos et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
A role for AMPA receptors in mood disorders
A Alt et al.
BIOCHEMICAL PHARMACOLOGY (2006)
被撤回的出版物: A randomized, double-blind, placebo-controlled study assessing the antiinflammatory effects of ketamine in cardiac surgical patient (Retracted article. See vol. 28, pg. 1435, 2014)
C Bartoc et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2006)
Glutamate-based therapeutic approaches: NR2B receptor antagonists
KR Gogas
CURRENT OPINION IN PHARMACOLOGY (2006)
A double-blind, placebo-controlled study of memantine in the treatment of major depression
CA Zarate et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Enhancement of translation elongation in neurons by brain-derived neurotrophic factor: Implications for mammalian target of rapamycin signaling
N Inamura et al.
JOURNAL OF NEUROCHEMISTRY (2005)
The role of glutamate in anxiety and related disorders
BM Cortese et al.
CNS SPECTRUMS (2005)
Glutamate modulators as novel interventions for mood disorders
SJ Mathew et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2005)
Mernantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons
JM Maler et al.
BRAIN RESEARCH (2005)
Ketamine attenuates liver injury attributed to endotoxemia: Role of cyclooxygenase-2
JW Suliburk et al.
SURGERY (2005)
The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat
D Bachteler et al.
NEUROPSYCHOPHARMACOLOGY (2005)
NMDA receptor-dependent regulation of axonal and dendritic branching
LJ Lee et al.
JOURNAL OF NEUROSCIENCE (2005)
Ketamine for paediatric sedation/analgesia in the emergency department
MC Howes
EMERGENCY MEDICINE JOURNAL (2004)
Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus
O Kaidanovich-Beilin et al.
BIOLOGICAL PSYCHIATRY (2004)
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
JM Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits
E Shimizu et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
The glamour and gloom of glycogen synthase kinase-3
RS Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium
WT O'Brien et al.
JOURNAL OF NEUROSCIENCE (2004)
Subtype-specific alterations of γ-aminobutyric acid and glutamate in patients with major depression
G Sanacora et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Can autophagy protect against neurodegeneration caused by aggregate-prone proteins?
B Ravikumar et al.
NEUROREPORT (2004)
Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites
N Takei et al.
JOURNAL OF NEUROSCIENCE (2004)
Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations
M Ribasés et al.
HUMAN MOLECULAR GENETICS (2004)
In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3
TD Gould et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism
IL Petrakis et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior
P Bäckström et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Determinants of trapping block of N-methyl-D-aspartate receptor channels
KV Bolshakov et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice
AO Rosa et al.
BEHAVIOURAL BRAIN RESEARCH (2003)
Glutamatergic systems in Alzheimer's disease
PT Francis
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Enhancement of antidepressant potency by a potentiator of AMPA receptors
X Li et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2003)
Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine
J De Vry et al.
BEHAVIOURAL PHARMACOLOGY (2003)
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression
HK Manji et al.
BIOLOGICAL PSYCHIATRY (2003)
Amantadine as augmentation therapy in the management of treatment-resistant depression
R Stryjer et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2003)
A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression
S Sen et al.
NEUROPSYCHOPHARMACOLOGY (2003)
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
MF Egan et al.
CELL (2003)
The dose-related effects of ketamine on mortality and cytokine responses to endotoxin-induced shock in rats
T Taniguchi et al.
ANESTHESIA AND ANALGESIA (2003)
The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications
JM Loftis et al.
PHARMACOLOGY & THERAPEUTICS (2003)
The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study
M Neves-Pereira et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Ras and Rap control AMPA receptor trafficking during synaptic plasticity
JJ Zhu et al.
CELL (2002)
Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats
Z Rogóz et al.
NEUROPHARMACOLOGY (2002)
Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model
RJ Knapp et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus
P Sklar et al.
MOLECULAR PSYCHIATRY (2002)
Prolonged effect of an anesthetic dose of ketamine on behavioral despair
A Yilmaz et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Ketamine inhibits endotoxin-induced shock in rats
T Taniguchi et al.
ANESTHESIOLOGY (2001)
Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes
I Mizuta et al.
NEUROSCIENCE LETTERS (2001)
Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine
M Narita et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
X Li et al.
NEUROPHARMACOLOGY (2001)
A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide
V Jevtovic-Todorovic et al.
BRAIN RESEARCH (2001)
Increased cerebrospinal fluid glutamine levels in depressed patients
J Levine et al.
BIOLOGICAL PSYCHIATRY (2000)
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine -: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists
A Anand et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial
DE Dietrich et al.
BIPOLAR DISORDERS (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
The responsiveness of the Hamilton Depression Rating Scale
D Faries et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2000)
分享论文
